Table 1.
Effects of polyphenols
| Authors | Year | Polyphenol | Type of study | Effects |
|---|---|---|---|---|
| Hong KB et al. [50] | 2022 | Tannase converted-green tea | In vitro | The levels of AMP-activated protein kinase-α (AMPKα) and muscle RING-finger protein-1 (MuRF-1) |
| Felice F et al. [51] | 2020 | Gallic acid | In vitro | ↓Atrogin-1, MuRF1 two muscle-specific ubiquitin ligases linked to muscle atrophy |
| Hour TC et al. [53] | 2022 | Quercetin | In vitro | ↑p-IGF-1R; regulating the ITGB1 signaling pathway and activating phosphorylation of FAK and paxillin |
| Funakoshi T et al. [54] | 2017 | Quercetin | In vitro and in vitro | ↑PPAR-g expression of FABP4 |
| Park SH et al. [55] | 2020 | Quercetin | In vivo and in vitro | The gene expression of atrogin-1 and MuRF1 and phosphorylation of AMPK |
| Suzuki K et al. [57] | 2020 | Theaflavins | In vivo | Anabolic Akt/mTOR pathway; phosphorylation of 4EBP-1 |
| Liu C et al. [58] | 2022 | Theaflavins | In vivo and in vitro | Expression of IL-1β, IL-6 and TNF-α by regulating the TLR4/MyD88/NF-κB signalling pathway |
| Aizawa T et al. [59] | 2017 | Theaflavins | Pilot study | Theaflavin had a beneficial effect on body fat and muscle |
| Fujiwara Y et al. [60] | 2017 | Oleuropein | RCT | ↑Traslocation of GLUT4 by activation of adenosine monophosphate-activated protein kinase (AMPK) |
| Razaei S [61] | 2018 | Olive oil | RCT | ↓Body fat mass, not reduced the skeletal mass |
| Santini SJ et al. [62] | 2020 | Oleuropein | In vivo and in vitro |
↓Fat in HepG2 cells ↓IL1-α and G-CSF ↑SOD2 cytosol expression |
| Santini SJ et al. [63] | 2022 | Oleuropein | In vivo and in vitro |
↓fat in HepG2 cells ↓copper content of FA-HepG2 Less body and liver weight; Improved the level of transaminases and lipid profile |
| Porcu C et al. [64] | 2018 | Oleuropein | In vivo and in vitro | ↑Activation of Akt/ULK1 pathway |